Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Hypertension Reports
Published in: Current Hypertension Reports 5/2010

01-10-2010

Hypertension in the Elderly: What Is the Goal Blood Pressure Target and How Can This Be Attained?

Authors: Bo Carlberg, Peter M. Nilsson

Published in: Current Hypertension Reports | Issue 5/2010

Login to get access

Abstract

For the aging populations of Europe, many emerging health problems in addition to myocardial infarction and stroke are associated with hypertension. Recently, the role of hypertension in the risk of vascular cognitive impairment and dementia has been highlighted, and there are studies to show that control of hypertension may slow this process. Furthermore, as many elderly individuals will also develop type 2 diabetes or impaired renal function, the risk of hypertension in these patients is more pronounced. New guidelines have tried to provide evidence-based treatment algorithms in which control of hypertension is just one aspect of general risk factor control, with the aim of decreasing the total risk.
Literature
1.
• Driver JA, Djoussé L, Logroscino G, et al.: Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ 2008, 337:a2467. This is an important epidemiologic observational study of morbidity and mortality in the oldest old. CrossRefPubMed
2.
Molander L, Lövheim H, Norman T, et al.: Lower systolic blood pressure is associated with greater mortality in people aged 85 and older. J Am Geriatr Soc 2008, 56:1853–1859.CrossRefPubMed
3.
Vasan RS, Beiser A, Seshadri S, et al.: Residual lifetime risk for developing hypertension in middle-aged women and men. The Framingham Heart Study. JAMA 2002, 287:1003–1010.CrossRefPubMed
4.
Coope J, Warrender TS: Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986, 293:1145–1150.CrossRefPubMed
5.
Amery A, Brixko R, Clement D: Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 1985, 328:589–592.CrossRef
6.
Prevention of stroke by antihypertensive drug treatment in older patients with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. JAMA 1991, 265:3255–3264.
7.
Staessen JA, Fagard R, Thijs L, et al.: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997, 350:757–764.CrossRefPubMed
8.
Dahlof B, Lindholm LH, Hansson L, et al.: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991, 338:1281–1285.CrossRefPubMed
9.
Medical Research Council Trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992, 304:405–412.
10.
Musini VM, Tejani AM, Bassett K, Wright JM: Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009, (4):CD000028.
11.
PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001, 358:1033–1041.CrossRef
12.
Rodgers A, Chapman N, Woodward M, et al.: Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. J Hypertens 2004, 22:653–659.CrossRefPubMed
13.
Gueyffier F, Bulpitt C, Boissel JP, et al.: Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. Lancet 1999, 353:793–796.CrossRefPubMed
14.
•• Beckett NS, Peters R, Fletcher AE, et al; HYVET Study Group: Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008, 358:1887–1898. This is the first and only randomized controlled trial investigating the effect of antihypertensive treatment on morbidity and mortality in patients more than 80 years of age.CrossRefPubMed
15.
• Peters R, Beckett N, Forette F, et al.: Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind placebo controlled trial. Lancet Neurol 2008, 7:683–689. This study showed that antihypertensive therapy prescribed to old patients does not increase the risk for dementia.CrossRefPubMed
16.
Messerli FH, Grossman E, Goldbourt U: Are β-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998, 279:1903–1907.CrossRefPubMed
17.
Khan N, McAlister FA: Re-examining the efficacy of β-blockers for the treatment of hypertension: a meta-analysis. CMAJ 2006, 174:1737–1742.PubMed
18.
Mancia G, de Backer G, Dominiczak A, et al.: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105–1187.CrossRefPubMed
19.
Mancia G, Laurent S, Agabiti-Rosei E, et al.: Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009 Oct 15 (Epub ahead of print).
20.
• Butt TF, Branch RL, Beesley L, Martin U: Managing hypertension in the very elderly: Effect of adverse drug reactions (ADRs) on achieving targets. J Hum Hypertens. 2010, 24:514–518. This article describes obstacles (such as problems related to adverse drug effects and interactions) in applying hypertension guidelines in old patients.
Metadata
Title
Hypertension in the Elderly: What Is the Goal Blood Pressure Target and How Can This Be Attained?
Authors
Bo Carlberg
Peter M. Nilsson
Publication date
01-10-2010
Publisher
Current Science Inc.
Published in
Current Hypertension Reports / Issue 5/2010
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-010-0138-y

Other articles of this Issue 5/2010

Current Hypertension Reports 5/2010 Go to the issue

Invited Commentary

The Diagnosis and Management of Syncope

ReviewPaper

Does Blockade of the Renin-Angiotensin-Aldosterone System Slow Progression of All Forms of Kidney Disease?

ReviewPaper

Is the Presence of Microalbuminuria a Relevant Marker of Kidney Disease?

ReviewPaper

Assessment of Cardiovascular Risk

ReviewPaper

Prevalence and Diagnosis of Primary Aldosteronism

ReviewPaper

Chronic Kidney Disease and Albuminuria in Arterial Hypertension
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits